Pular para o conteúdo
Merck
  • Repair of spinal cord injury by inhibition of astrocyte growth and inflammatory factor synthesis through local delivery of flavopiridol in PLGA nanoparticles.

Repair of spinal cord injury by inhibition of astrocyte growth and inflammatory factor synthesis through local delivery of flavopiridol in PLGA nanoparticles.

Biomaterials (2014-05-09)
Hao Ren, Min Han, Jing Zhou, Ze-Feng Zheng, Ping Lu, Jun-Juan Wang, Jia-Qiu Wang, Qi-Jiang Mao, Jian-Qing Gao, Hong Wei Ouyang
RESUMO

The cell-cycle inhibitor flavopiridol has been shown to improve recovery from spinal cord injury in animal models. However, the systemic dose of flavopiridol has side-effects and the mechanism of action is not clear. This study aimed to develop a strategy for the local delivery of flavopiridol and investigate its mechanisms of action. Poly(lactic-co-glycolic acid) (PLGA) nanoparticles (NPs) were used for the sustained delivery of flavopiridol. The spinal cord was right-hemisectioned and NPs were delivered into the injury site. Transparent spinal cord technology was used for the three-dimensional observation of anterograde tracing. The results showed that flavopiridol NPs had a sustained release of up to 3 days in vitro. Flavopiridol NPs significantly decreased inflammatory factor synthesis by astrocytes, including TNF-α, IL-1β, and IL-6, while the IL-10 expression was elevated. In vivo study demonstrated that flavopiridol NPs decreased cell-cycle activation, inflammatory expression and glial scarring, and facilitated neuronal survival and regeneration. The cavitation volume was decreased by ~90%. Administration of flavopiridol NPs also improved the motor recovery of injured animals. These findings demonstrated that local delivery of flavopiridol in PLGA NPs improves recovery from spinal cord injury by inhibiting astrocyte growth and inflammatory factor synthesis.

MATERIAIS
Número do produto
Marca
Descrição do produto

Sigma-Aldrich
Diclorometano, suitable for HPLC, ≥99.8%, contains amylene as stabilizer
Sigma-Aldrich
Diclorometano, contains 40-150 ppm amylene as stabilizer, ACS reagent, ≥99.5%
Sigma-Aldrich
Diclorometano, HPLC Plus, for HPLC, GC, and residue analysis, ≥99.9%, contains 50-150 ppm amylene as stabilizer
Sigma-Aldrich
Diclorometano, anhydrous, ≥99.8%, contains 40-150 ppm amylene as stabilizer
Sigma-Aldrich
Diclorometano, ACS reagent, ≥99.5%, contains 40-150 ppm amylene as stabilizer
Sigma-Aldrich
Diclorometano, puriss. p.a., ACS reagent, reag. ISO, ≥99.9% (GC)
Sigma-Aldrich
Diclorometano, puriss., meets analytical specification of Ph. Eur., NF, ≥99% (GC)
Supelco
Diclorometano, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Diclorometano, ACS reagent, ≥99.5%, contains 40-150 ppm amylene as stabilizer
Sigma-Aldrich
Diclorometano, suitable for HPLC, ≥99.9%, contains 40-150 ppm amylene as stabilizer
Supelco
Diclorometano, analytical standard
Sigma-Aldrich
Diclorometano, biotech. grade, 99.9%, contains 40-150 ppm amylene as stabilizer
Supelco
Dichloromethane solution, certified reference material, 5000 μg/mL in methanol
Supelco
Diclorometano, Selectophore, ≥99.5%
Sigma-Aldrich
β-D-Allose, rare aldohexose sugar